Suppr超能文献

相似文献

1
Quantitative telemedicine ratings in Batten disease: implications for rare disease research.
Neurology. 2011 Nov 15;77(20):1808-11. doi: 10.1212/WNL.0b013e3182377e29. Epub 2011 Oct 19.
2
The Unified Batten Disease Rating Scale (UBDRS): Validation and reliability in an independent CLN3 disease sample.
Eur J Paediatr Neurol. 2022 May;38:62-65. doi: 10.1016/j.ejpn.2022.03.005. Epub 2022 Apr 4.
3
Quantifying physical decline in juvenile neuronal ceroid lipofuscinosis (Batten disease).
Neurology. 2011 Nov 15;77(20):1801-7. doi: 10.1212/WNL.0b013e318237f649. Epub 2011 Oct 19.
5
A clinical rating scale for Batten disease: reliable and relevant for clinical trials.
Neurology. 2005 Jul 26;65(2):275-9. doi: 10.1212/01.wnl.0000169019.41332.8a.
7
The CLN3 Disease Staging System: A new tool for clinical research in Batten disease.
Neurology. 2020 Jun 9;94(23):e2436-e2440. doi: 10.1212/WNL.0000000000009454. Epub 2020 Apr 16.
8
Reliability of remote video ratings of the scale for assessment and rating of ataxia.
Parkinsonism Relat Disord. 2025 Mar;132:107278. doi: 10.1016/j.parkreldis.2025.107278. Epub 2025 Jan 13.
9
Is a Three-component Video-based Version of the Foot Posture Index Valid for Assessing Pediatric Patients With Orthopaedic and Neurologic Foot Conditions?
Clin Orthop Relat Res. 2024 Nov 1;482(11):2063-2071. doi: 10.1097/CORR.0000000000003110. Epub 2024 May 9.
10
Measuring to improve: a new rating scale for Batten disease.
Neurology. 2011 Nov 15;77(20):1779-80. doi: 10.1212/WNL.0b013e3182377e6f. Epub 2011 Oct 19.

引用本文的文献

1
Speech, Language and Non-verbal Communication in CLN2 and CLN3 Batten Disease.
J Inherit Metab Dis. 2025 Jan;48(1):e12838. doi: 10.1002/jimd.12838.
2
Understanding dentatorubral-pallidoluysian atrophy (DRPLA) symptoms and impacts on daily life: a qualitative interview study with patients and caregivers.
Ther Adv Rare Dis. 2024 May 20;5:26330040241252447. doi: 10.1177/26330040241252447. eCollection 2024 Jan-Dec.
3
What role can decentralized trial designs play to improve rare disease studies?
Orphanet J Rare Dis. 2022 Jun 20;17(1):240. doi: 10.1186/s13023-022-02388-5.
5
Practicing in a Pandemic: A Clinician's Guide to Remote Neurologic Care.
Neurol Clin Pract. 2021 Apr;11(2):e179-e188. doi: 10.1212/CPJ.0000000000000882.
6
Rare disease care pathways in the EU: from odysseys and labyrinths towards highways.
J Community Genet. 2021 Apr;12(2):231-239. doi: 10.1007/s12687-021-00520-9. Epub 2021 Mar 18.
7
Video research visits for atypical parkinsonian syndromes among Fox Trial Finder participants.
Neurol Clin Pract. 2020 Feb;10(1):7-14. doi: 10.1212/CPJ.0000000000000680.
8
Therapeutic landscape for Batten disease: current treatments and future prospects.
Nat Rev Neurol. 2019 Mar;15(3):161-178. doi: 10.1038/s41582-019-0138-8.
9
The Promise of Telemedicine for Movement Disorders: an Interdisciplinary Approach.
Curr Neurol Neurosci Rep. 2018 Apr 13;18(5):26. doi: 10.1007/s11910-018-0834-6.
10
National randomized controlled trial of virtual house calls for Parkinson disease.
Neurology. 2017 Sep 12;89(11):1152-1161. doi: 10.1212/WNL.0000000000004357. Epub 2017 Aug 16.

本文引用的文献

1
Quantifying physical decline in juvenile neuronal ceroid lipofuscinosis (Batten disease).
Neurology. 2011 Nov 15;77(20):1801-7. doi: 10.1212/WNL.0b013e318237f649. Epub 2011 Oct 19.
3
Neuropsychological symptoms of juvenile-onset batten disease: experiences from 2 studies.
J Child Neurol. 2007 May;22(5):621-7. doi: 10.1177/0883073807302603.
4
A clinical rating scale for Batten disease: reliable and relevant for clinical trials.
Neurology. 2005 Jul 26;65(2):275-9. doi: 10.1212/01.wnl.0000169019.41332.8a.
6
Dementia in the neuronal ceroid-lipofuscinoses.
Adv Exp Med Biol. 2001;487:211-7.
7
Neuronal ceroid lipofuscinoses in childhood.
Neurol Sci. 2000;21(3 Suppl):S35-41. doi: 10.1007/s100720070038.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验